Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin

This publication has 22 references indexed in Scilit:

• Anti-Inflammatory Activity of Two Flavonoids from Tanacetum microphyllum
  Journal of Natural Products, 1993
• Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum(II)
  Gynecologic Oncology, 1992
• Effect of the flavanolignans of Silybum marianum L. On lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes
  Pharmacological Research, 1992
• Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites
  Cancer Chemotherapy and Pharmacology, 1991
• Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells
  British Journal of Cancer, 1990
• Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids
  British Journal of Haematology, 1990
• Enhancement of the antiproliferative activity of cis‐diamminedichloroplatinum(II) by quercetin
  International Journal of Cancer, 1990
• Natural Products as a Source of Potential Cancer Chemotherapeutic and Chemopreventive Agents
  Journal of Natural Products, 1990
• Bioflavonoid interaction with rat uterine type ii binding sites and cell growth inhibition
  Journal of Steroid Biochemistry, 1988
• Disposition of quercetin in man after single oral and intravenous doses
  European Journal of Clinical Pharmacology, 1975